Weigang Shu

13 total papers · 456 total citations
10 papers, 364 citations indexed

About

Weigang Shu is a scholar working on Genetics, Immunology and Oncology. According to data from OpenAlex, Weigang Shu has authored 10 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Immunology and 2 papers in Oncology. Recurrent topics in Weigang Shu's work include Inflammatory Bowel Disease (5 papers), IL-33, ST2, and ILC Pathways (4 papers) and Immune cells in cancer (2 papers). Weigang Shu is often cited by papers focused on Inflammatory Bowel Disease (5 papers), IL-33, ST2, and ILC Pathways (4 papers) and Immune cells in cancer (2 papers). Weigang Shu collaborates with scholars based in China, United States and Canada. Weigang Shu's co-authors include Zhanju Liu, Wei Wu, Zhi Pang, Guangxi Zhou, Mingming Sun, Leilei Fang, Yingzi Cong, Jian Lin, Huili Wu and Cui Zhang and has published in prestigious journals such as Gastroenterology, Carcinogenesis and Inflammatory Bowel Diseases.

In The Last Decade

Weigang Shu

10 papers receiving 363 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Weigang Shu 146 141 101 63 58 10 364
Ritian Lin 162 1.1× 132 0.9× 79 0.8× 43 0.7× 42 0.7× 17 336
Alessia Butera 171 1.2× 160 1.1× 114 1.1× 27 0.4× 66 1.1× 15 389
Tyralee Goo 107 0.7× 199 1.4× 58 0.6× 49 0.8× 45 0.8× 8 378
Shikha Nayar 126 0.9× 101 0.7× 80 0.8× 41 0.7× 40 0.7× 10 293
Gerolamo Bevivino 116 0.8× 106 0.8× 143 1.4× 77 1.2× 77 1.3× 18 345
Marja B. van der Ende 85 0.6× 183 1.3× 63 0.6× 44 0.7× 40 0.7× 15 356
Scott Levison 87 0.6× 132 0.9× 69 0.7× 42 0.7× 42 0.7× 13 333
J.‐M. Otte 171 1.2× 65 0.5× 113 1.1× 49 0.8× 107 1.8× 11 391
Ziad Alnadjim 155 1.1× 93 0.7× 76 0.8× 64 1.0× 44 0.8× 9 360
Kazutami Tamura 113 0.8× 136 1.0× 99 1.0× 27 0.4× 72 1.2× 11 363

Countries citing papers authored by Weigang Shu

Since Specialization
Citations

This map shows the geographic impact of Weigang Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weigang Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weigang Shu more than expected).

Fields of papers citing papers by Weigang Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weigang Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weigang Shu. The network helps show where Weigang Shu may publish in the future.

Co-authorship network of co-authors of Weigang Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Weigang Shu. A scholar is included among the top collaborators of Weigang Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weigang Shu. Weigang Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026